Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: nested cohort crossover study.
about
Oral PUVA and topical steroids for treatment of oral manifestations of chronic graft-vs.-host disease.De novo papillary carcinoma in a renal allograft: the pros and cons of immunosuppressionChronic phototoxicity and aggressive squamous cell carcinoma of the skin in children and adults during treatment with voriconazole.Association of suicide attempts with acne and treatment with isotretinoin: retrospective Swedish cohort study.Systemic methotrexate therapy for psoriasis: past, present and future.Etanercept in the treatment of plaque psoriasisRoles of the immune system in skin cancer.Transition from methotrexate and cyclosporine to other therapies including retinoids, ultraviolet light and biologic agents in the management of patients with psoriasis.Ciclosporin in psoriasis clinical practice: an international consensus statement.Iatrogenic skin cancer: induction by psoralen/ultraviolet A and immunosuppression of organ transplant recipients.Psoralen ultraviolet A therapy in 2004.The role of TGF-beta in epithelial malignancy and its relevance to the pathogenesis of oral cancer (part II).Sirolimus effects on cancer incidence after kidney transplantation: a meta-analysis.Lymphomatoid papulosis in a patient with atopic eczema on long-term ciclosporin therapy.Review of the potential photo-cocarcinogenicity of topical calcineurin inhibitors: position statement of the European Dermatology Forum.The use of ciclosporin in psoriasis.Recommendations for the use of etanercept in psoriasis: a European dermatology expert group consensus.Cyclosporin in the treatment of patients with atopic eczema - a systematic review and meta-analysis.Cyclosporin-A associated malignancy.Targeted treatment of psoriasis with adalimumab: a critical appraisal based on a systematic review of the literature.Association between cancer and immunosuppressive therapy--analysis of selected studies in pemphigus and pemphigoid.Strategies for improving the quality of care in psoriasis with the use of treatment goals--a report on an implementation meeting.Eczema and cancer risk: a critical appraisal and review of the literature.Cyclosporine and skin cancer: an international dermatologic perspective over 25 years of experience. A comprehensive review and pursuit to define safe use of cyclosporine in dermatology.Therapeutic strategies in psoriasis patients with psoriatic arthritis: focus on new agents.Risk of cancer in psoriasis: a systematic review and meta-analysis of epidemiological studies.Psoriasis: to treat or to manage?Hand dermatitis: a review of clinical features, prevention and treatment.Clinical experience with systemic cyclosporine A treatment in severe childhood psoriasis.Spectrum of Immune-Related Conditions Associated with Risk of Keratinocyte Cancers among Elderly Adults in the United States.Trade-offs between the benefits and risks of drug treatment for psoriasis: a discrete choice experiment with U.K. dermatologists.Cutaneous malignancies during treatment with efalizumab and infliximab: When temporal relationship does not mean causality.The risk of developing non-melanoma skin cancer, lymphoma and melanoma in patients with psoriasis in Taiwan: a 10-year, population-based cohort study.Efalizumab in routine use: a clinical experience.Combining PUVA therapy with systemic immunosuppression to treat progressive diffuse morphoea.Multiple papillomavirus-associated epidermal hamartomas and squamous cell carcinomas in situ in a dog following chronic treatment with prednisone and cyclosporine.Malignancy Risk and Recurrence with Psoriasis and its Treatments: A Concise Update.S1-Guidelines on UV phototherapy and photochemotherapy.British Association of Dermatologists and British Photodermatology Group guidelines for the safe and effective use of psoralen-ultraviolet A therapy 2015.S3 - Guidelines on the treatment of psoriasis vulgaris (English version). Update.
P2860
Q33204503-19203C2A-9877-4196-B964-6C4995DF74DCQ33622320-BD0431D1-966C-4B98-B0AC-76BEB9AB4124Q33626342-82917F0D-1E9F-470F-A134-7F28D3777C64Q34300022-E3D56F6A-AB01-46D9-86A9-8AC31898909BQ34356265-9C8088B5-6365-4A59-849B-2CDDBEE13251Q34620263-68A8B186-5BF1-4CCF-A861-8C45B242F441Q35403714-5AA746A3-B8FC-4517-A37E-8D2A6D077A3AQ35567825-24E2052A-33A2-41EF-84BA-E314CA73D83BQ35759170-30A716EB-2BC7-43E5-85A8-08670F7131FDQ35943114-7F55A777-9EEF-420E-B549-375A5F548707Q35943136-86C1C269-431A-46C9-B599-9C7721293743Q35969342-BA673EA9-B7E0-4BB3-8515-1FBD2E54EF20Q36051817-2E6FFB9E-45E6-4ADE-925A-D548A319F546Q36158960-84B656A9-BC51-40D7-B70E-88550AF397A1Q36305883-BA87410A-634B-4A85-8F48-E3FF86EE3ADDQ36374570-74A9CBAE-4968-4823-8707-AE8443853F8DQ36572788-4FC4760F-3A27-4D4E-97A2-9CA82B1C1422Q36797258-C66D3F24-12CF-4463-B36C-053E31F3048EQ37247310-6BDA62FA-2AA6-4767-8EB1-165310CD3BBBQ37303223-11B8C727-2692-4ECB-A8FD-CA91CD93511EQ37798091-270CDA63-61B0-4465-A21C-86517F275443Q37862369-C3540EC9-DAC2-4566-9DCC-6BF53FDBC0E7Q37925037-55D0C461-4836-472B-B86D-6F00FD47881AQ37936458-85195506-F8C9-4A76-9C58-9C2D878C9654Q38098466-62ABB092-D0D3-4AF1-852F-068FD9842881Q38120851-C11EE074-2EA1-4C8A-B43E-6EF730EE44C1Q38210780-747EB457-4F45-45CF-8053-014D5B4A67C3Q38446594-A3BFFA8A-027A-4DBA-8DD8-F85566630280Q40228512-8D4B228E-58E7-42E6-A029-5F3DD5346466Q40257939-81A97AA5-D38E-4776-80E5-E4EA96D6C23FQ40269632-024B510F-9313-4E4D-AB1A-1E7147F84353Q43625754-8DA81692-8672-4C59-A4A3-C1480E8F57BEQ43944988-F55156B6-3535-4BE1-8DB4-E8DB9A1BA1A9Q44124198-C9D2F1BA-5D85-4AD0-A387-61199AC5E85FQ46419498-90821AA5-2FCA-4AFD-92BA-B984D7381013Q46765363-725033DE-001D-44AE-A184-D9284F55149BQ48089393-B7B16BAC-8C91-4E26-B97D-0F5DFE857220Q51206994-3F98D0DF-07DB-4A94-874D-9F52EE8BB4AEQ52818545-090A21B2-3CBA-4F6D-92B6-B1C0BD33BB63Q52888818-1A1032B5-1919-4788-8194-E5E00D27AC8E
P2860
Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: nested cohort crossover study.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Squamous-cell cancer of the sk ...... nested cohort crossover study.
@en
Squamous-cell cancer of the sk ...... nested cohort crossover study.
@nl
type
label
Squamous-cell cancer of the sk ...... nested cohort crossover study.
@en
Squamous-cell cancer of the sk ...... nested cohort crossover study.
@nl
prefLabel
Squamous-cell cancer of the sk ...... nested cohort crossover study.
@en
Squamous-cell cancer of the sk ...... nested cohort crossover study.
@nl
P1433
P1476
Squamous-cell cancer of the sk ...... nested cohort crossover study.
@en
P2093
P304
P356
10.1016/S0140-6736(01)06179-7
P407
P577
2001-09-01T00:00:00Z